BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 11863316)

  • 1. Vascular diseases: new results with pentoxifylline.
    Belcaro G; Cesarone MR; Ippolito E
    Angiology; 2002; 53 Suppl 1():1 p following TOC. PubMed ID: 11863316
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of vascular inner ear disease with pentoxifylline: a 4-week, controlled, randomized trial.
    Incandela L; Cesarone MR; Belcaro G; De Sanctis MT; Nicolaides AN; Griffin M; Geroulakos G; Ramaswami G
    Angiology; 2002; 53 Suppl 1():S19-22. PubMed ID: 11865830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of vascular inner ear disease in vascular patients with pentoxifylline: a controlled, randomized trial.
    Cesarone MR; Incandela L; Belcaro G; De Sanctis MT; Nicolaides AN; Griffin M; Geroulakos G; Ramaswami G
    Angiology; 2002; 53 Suppl 1():S23-6. PubMed ID: 11865831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic control of the path of the blood flow of the end organs].
    Gersmeyer EF; Leicht E
    Med Welt; 1967 Feb; 8():426-31. PubMed ID: 6044562
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results of a clinical study on the vasodilator 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
    Lehrach F; Müller R
    Arzneimittelforschung; 1971 Aug; 21(8):1171-4. PubMed ID: 5110012
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic results in disturbed peripheral blood circulation with the vasodilator bencyclane].
    Leonard W
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1440+. PubMed ID: 5536666
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of Vasculat on the peripheral blood circulation and the economy of circulatory function].
    Herrwerth E; Brenner L
    Med Klin; 1966 Dec; 61(49):1969-71. PubMed ID: 5339977
    [No Abstract]   [Full Text] [Related]  

  • 8. [When are vasodilator agents effective in arterial occlusive diseases? Plethysmographic measurements in a double blind trial].
    Baitsch G; Schäfer M
    Med Welt; 1969 Aug; 35():1910-3. PubMed ID: 4897422
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy of vasoactive agents in clinical practice].
    Coget JM
    Phlebologie; 1990; 43(4):707-13. PubMed ID: 2093930
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of a new vascular drug, 4216 S, on circulatory flow in patients with chronic angiopathy of the lower extremities: determination of an index of vascularization of the lower extremities by serum albumin tagged with iodine 131].
    Dugois P; Bignicourt B
    Lyon Med; 1969 Jul; 222(27):43-7. PubMed ID: 5398723
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of vascular retinal disease with pentoxifylline: a controlled, randomized trial.
    Incandela L; Cesarone MR; Belcaro G; Steigerwalt R; De Sanctis MT; Nicolaides AN; Griffin M; Geroulakos G; Ramaswami G
    Angiology; 2002; 53 Suppl 1():S31-4. PubMed ID: 11865833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Compensation grade of arterial occlusions and action of intravenously administered vasoactive drugs].
    Bollinger A; Lüthy E
    Helv Med Acta Suppl; 1967 May; 47():128. PubMed ID: 5286297
    [No Abstract]   [Full Text] [Related]  

  • 13. [Correlations between reactive hyperemia and response to vasodilator agents in patients with obliterating arteriopathies of the lower limbs].
    Dabizzi RP; Fantini F; Cappelli G; Grandonico F
    Minerva Cardioangiol; 1970 May; 18(5):287-90. PubMed ID: 5515012
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug therapy of peripheral arterial blood circulation disorders].
    Bollinger A
    Dtsch Med Wochenschr; 1969 Nov; 94(45):2347-9. PubMed ID: 5346859
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of bencyclane on burns and other functional vascular disorders].
    Novák J; Gavallér L
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1437+. PubMed ID: 4394926
    [No Abstract]   [Full Text] [Related]  

  • 16. [Disorders of spinal circulation].
    Lapshun MI
    Vrach Delo; 1969 May; 5():77-80. PubMed ID: 5368898
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the therapy of peripheral circulatory disorders with the new angioactivator Tebonin of plant origin].
    Krammer F
    Med Welt; 1966 Jul; 28():1524-8. PubMed ID: 5984513
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemorheology and peripheral vascular diseases: a new therapeutic approach.
    Müller R
    J Med; 1981; 12(4):209-35. PubMed ID: 7031157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical results in therapy of peripheral vascular diseases with ginkgo-biloba].
    Bartolo M
    Minerva Med; 1973 Nov; 64(79 Suppl):4187-93. PubMed ID: 4592295
    [No Abstract]   [Full Text] [Related]  

  • 20. [Letter: So-called vasodilator agents in conservative vascular therapy].
    Fischer H
    Hautarzt; 1975 Feb; 26(2):108-9. PubMed ID: 1126839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.